Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

MediWound Ltd. (MDWD) Institutional Ownership & Insider Trading

79 institutions reported holding MediWound Ltd. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 11 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MDWDMediWound Ltd.Follow MDWD — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
154.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

79 institutions held 45.3% of the shares. Across filers that reported both quarters, shares held changed -3.8%.

Increased+28New+13Decreased-15Closed-7

Largest moves, shares (millions)

BlackRock+0.1MAQR Capital Management+0.1MPhoenix Financial+0.0MMeitav Investment House-0.4MT. Rowe Price Associates-0.1MPoint72 Asset Management-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+1.5Sep 24+0.2Dec 24-0.1Mar 25+0.2Jun 25+1.3Sep 25+0.1Dec 25+0.2Mar 26-0.2Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26796-3.8%2813157
Mar 26756+3.2%23141516
Dec 25776+1.8%3011169
Sep 25746+29.9%27141310
Jun 25684+3.6%188224
Mar 25644-3.2%238178
Dec 24644+5.5%225114
Sep 24634+66.7%1520173

MediWound Ltd. — questions

Who owns MediWound Ltd. stock?
79 institutions reported MediWound Ltd. shares in 13F filings for the quarter ended 2026-06-30. The largest: INVESTOR AB (6.8%), Yelin Lapidot Holdings Management Ltd. (5.9%), Rosalind Advisors, Inc. (5.8%).
Are MediWound Ltd. insiders buying or selling?
11 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from MediWound Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.